190 related articles for article (PubMed ID: 26647963)
21. The effects of polyphenol supplementation on adipose tissue morphology and gene expression in overweight and obese humans.
Most J; Warnke I; Boekschoten MV; Jocken JWE; de Groot P; Friedel A; Bendik I; Goossens GH; Blaak EE
Adipocyte; 2018; 7(3):190-196. PubMed ID: 29786471
[TBL] [Abstract][Full Text] [Related]
22. Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo.
Hagström-Toft E; Thörne A; Reynisdottir S; Moberg E; Rössner S; Bolinder J; Arner P
Diabetes; 2001 Jul; 50(7):1604-11. PubMed ID: 11423482
[TBL] [Abstract][Full Text] [Related]
23. Decaffeinated green tea extract rich in epigallocatechin-3-gallate improves insulin resistance and metabolic profiles in normolipidic diet--but not high-fat diet-fed mice.
Santana A; Santamarina A; Souza G; Mennitti L; Okuda M; Venancio D; Seelaender M; do Nascimento CO; Ribeiro E; Lira F; Oyama L
J Nutr Biochem; 2015 Sep; 26(9):893-902. PubMed ID: 26048201
[TBL] [Abstract][Full Text] [Related]
24. Intramuscular adaptations to eccentric exercise and antioxidant supplementation.
Kerksick CM; Kreider RB; Willoughby DS
Amino Acids; 2010 Jun; 39(1):219-32. PubMed ID: 19967420
[TBL] [Abstract][Full Text] [Related]
25. Dairy calcium supplementation in overweight or obese persons: its effect on markers of fat metabolism.
Bortolotti M; Rudelle S; Schneiter P; Vidal H; Loizon E; Tappy L; Acheson KJ
Am J Clin Nutr; 2008 Oct; 88(4):877-85. PubMed ID: 18842771
[TBL] [Abstract][Full Text] [Related]
26. Dietary (-)-Epigallocatechin-3-gallate Supplementation Counteracts Aging-Associated Skeletal Muscle Insulin Resistance and Fatty Liver in Senescence-Accelerated Mouse.
Liu HW; Chan YC; Wang MF; Wei CC; Chang SJ
J Agric Food Chem; 2015 Sep; 63(38):8407-17. PubMed ID: 26152236
[TBL] [Abstract][Full Text] [Related]
27. The effects of long-term valsartan treatment on skeletal muscle fatty acid handling in humans with impaired glucose metabolism.
Moors CC; Blaak EE; van der Zijl NJ; Diamant M; Goossens GH
J Clin Endocrinol Metab; 2013 May; 98(5):E891-6. PubMed ID: 23553863
[TBL] [Abstract][Full Text] [Related]
28. Influence of short-term consumption of the caffeine-free, epigallocatechin-3-gallate supplement, Teavigo, on resting metabolism and the thermic effect of feeding.
Lonac MC; Richards JC; Schweder MM; Johnson TK; Bell C
Obesity (Silver Spring); 2011 Feb; 19(2):298-304. PubMed ID: 20725062
[TBL] [Abstract][Full Text] [Related]
29. (-)-Epigallocatechin-3-gallate increases the expression of genes related to fat oxidation in the skeletal muscle of high fat-fed mice.
Sae-Tan S; Grove KA; Kennett MJ; Lambert JD
Food Funct; 2011 Feb; 2(2):111-6. PubMed ID: 21779555
[TBL] [Abstract][Full Text] [Related]
30. Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice.
Murase T; Haramizu S; Shimotoyodome A; Nagasawa A; Tokimitsu I
Am J Physiol Regul Integr Comp Physiol; 2005 Mar; 288(3):R708-15. PubMed ID: 15563575
[TBL] [Abstract][Full Text] [Related]
31. The effects of catechin rich teas and caffeine on energy expenditure and fat oxidation: a meta-analysis.
Hursel R; Viechtbauer W; Dulloo AG; Tremblay A; Tappy L; Rumpler W; Westerterp-Plantenga MS
Obes Rev; 2011 Jul; 12(7):e573-81. PubMed ID: 21366839
[TBL] [Abstract][Full Text] [Related]
32. Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial.
Brown AL; Lane J; Holyoak C; Nicol B; Mayes AE; Dadd T
Br J Nutr; 2011 Dec; 106(12):1880-9. PubMed ID: 21736785
[TBL] [Abstract][Full Text] [Related]
33. Changes in skeletal muscle proteolytic gene expression after prophylactic supplementation of EGCG and NAC and eccentric damage.
Kerksick CM; Roberts MD; Dalbo VJ; Kreider RB; Willoughby DS
Food Chem Toxicol; 2013 Nov; 61():47-52. PubMed ID: 23376779
[TBL] [Abstract][Full Text] [Related]
34. The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: a double-blind, randomized control trial.
Mangine GT; Gonzalez AM; Wells AJ; McCormack WP; Fragala MS; Stout JR; Hoffman JR
Lipids Health Dis; 2012 Oct; 11():127. PubMed ID: 23033919
[TBL] [Abstract][Full Text] [Related]
35. Dietary supplementation with (-)-epigallocatechin-3-gallate reduces inflammatory response in adipose tissue of non-obese type 2 diabetic Goto-Kakizaki (GK) rats.
Uchiyama Y; Suzuki T; Mochizuki K; Goda T
J Agric Food Chem; 2013 Nov; 61(47):11410-7. PubMed ID: 24206061
[TBL] [Abstract][Full Text] [Related]
36. Induction of oxidatively modified proteins in skeletal muscle by electrical stimulation and its suppression by dietary supplementation of (-)-epigallocatechin gallate.
Nagasawa T; Hayashi H; Fujimaki N; Nishizawa N; Kitts DD
Biosci Biotechnol Biochem; 2000 May; 64(5):1004-10. PubMed ID: 10879470
[TBL] [Abstract][Full Text] [Related]
37. Effects of epigallocatechin gallate on lipid metabolism and its underlying molecular mechanism in broiler chickens.
Huang JB; Zhang Y; Zhou YB; Wan XC; Zhang JS
J Anim Physiol Anim Nutr (Berl); 2015 Aug; 99(4):719-27. PubMed ID: 25521589
[TBL] [Abstract][Full Text] [Related]
38. Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadricep muscle and adipose tissue. Evidence for significant lipolysis in skeletal muscle.
Maggs DG; Jacob R; Rife F; Lange R; Leone P; During MJ; Tamborlane WV; Sherwin RS
J Clin Invest; 1995 Jul; 96(1):370-7. PubMed ID: 7615807
[TBL] [Abstract][Full Text] [Related]
39. Administration of a dietary supplement ( N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: a randomized controlled trial.
Rondanelli M; Opizzi A; Solerte SB; Trotti R; Klersy C; Cazzola R
Br J Nutr; 2009 Feb; 101(3):457-64. PubMed ID: 18590587
[TBL] [Abstract][Full Text] [Related]
40. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Westerterp-Plantenga MS; Lejeune MP; Kovacs EM
Obes Res; 2005 Jul; 13(7):1195-204. PubMed ID: 16076989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
